Chinese expert consensus on diagnosis and treatment of coagulation dysfunction in COVID-19.
Mil Med Res
; 7(1): 19, 2020 04 20.
Artigo
em Inglês
| MEDLINE | ID: covidwho-72008
ABSTRACT
Since December 2019, a novel type of coronavirus disease (COVID-19) in Wuhan led to an outbreak throughout China and the rest of the world. To date, there have been more than 1,260,000 COVID-19 patients, with a mortality rate of approximately 5.44%. Studies have shown that coagulation dysfunction is a major cause of death in patients with severe COVID-19. Therefore, the People's Liberation Army Professional Committee of Critical Care Medicine and Chinese Society on Thrombosis and Hemostasis grouped experts from the frontline of the Wuhan epidemic to come together and develop an expert consensus on diagnosis and treatment of coagulation dysfunction associated with a severe COVID-19 infection. This consensus includes an overview of COVID-19-related coagulation dysfunction, tests for coagulation, anticoagulation therapy, replacement therapy, supportive therapy and prevention. The consensus produced 18 recommendations which are being used to guide clinical work.
Palavras-chave
Texto completo:
Disponível
Coleções:
Bases de dados internacionais
Base de dados:
MEDLINE
Assunto principal:
Pneumonia Viral
/
Transtornos da Coagulação Sanguínea
/
Infecções por Coronavirus
/
Betacoronavirus
Tipo de estudo:
Estudo diagnóstico
/
Estudo prognóstico
Tópicos:
Covid persistente
Limite:
Idoso
/
Humanos
/
Meia-Idade
País/Região como assunto:
Ásia
Idioma:
Inglês
Revista:
Mil Med Res
Ano de publicação:
2020
Tipo de documento:
Artigo
País de afiliação:
S40779-020-00247-7
Similares
MEDLINE
...
LILACS
LIS